全文获取类型
收费全文 | 6326篇 |
免费 | 571篇 |
国内免费 | 219篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 400篇 |
妇产科学 | 33篇 |
基础医学 | 801篇 |
口腔科学 | 15篇 |
临床医学 | 385篇 |
内科学 | 486篇 |
皮肤病学 | 44篇 |
神经病学 | 334篇 |
特种医学 | 91篇 |
外科学 | 3015篇 |
综合类 | 640篇 |
现状与发展 | 4篇 |
预防医学 | 282篇 |
眼科学 | 270篇 |
药学 | 210篇 |
中国医学 | 34篇 |
肿瘤学 | 47篇 |
出版年
2024年 | 5篇 |
2023年 | 86篇 |
2022年 | 90篇 |
2021年 | 192篇 |
2020年 | 203篇 |
2019年 | 222篇 |
2018年 | 260篇 |
2017年 | 259篇 |
2016年 | 211篇 |
2015年 | 195篇 |
2014年 | 311篇 |
2013年 | 442篇 |
2012年 | 317篇 |
2011年 | 316篇 |
2010年 | 293篇 |
2009年 | 338篇 |
2008年 | 344篇 |
2007年 | 330篇 |
2006年 | 370篇 |
2005年 | 329篇 |
2004年 | 301篇 |
2003年 | 265篇 |
2002年 | 209篇 |
2001年 | 191篇 |
2000年 | 160篇 |
1999年 | 129篇 |
1998年 | 117篇 |
1997年 | 93篇 |
1996年 | 94篇 |
1995年 | 58篇 |
1994年 | 83篇 |
1993年 | 41篇 |
1992年 | 65篇 |
1991年 | 30篇 |
1990年 | 19篇 |
1989年 | 38篇 |
1988年 | 17篇 |
1987年 | 13篇 |
1986年 | 8篇 |
1985年 | 14篇 |
1984年 | 9篇 |
1983年 | 10篇 |
1982年 | 6篇 |
1981年 | 4篇 |
1980年 | 7篇 |
1979年 | 8篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1975年 | 3篇 |
1973年 | 2篇 |
排序方式: 共有7116条查询结果,搜索用时 31 毫秒
81.
82.
Calcineurin Inhibitor Withdrawal from Sirolimus-Based Therapy in Kidney Transplantation: A Systematic Review of Randomized Trials 总被引:4,自引:0,他引:4
Atul V. Mulay Naser Hussain Dean Fergusson Greg A. Knoll 《American journal of transplantation》2005,5(7):1748-1756
Calcineurin inhibitor (CNI) withdrawal has been used as a strategy to improve renal allograft function, however, it also carries risk of acute rejection. We conducted a systematic review of randomized trials that involved CNI withdrawal from a sirolimus-based immunosuppressive regimen. The search strategy yielded six trials (n = 1047 patients) reported in eight publications. CNI withdrawal from sirolimus-based therapy, was associated with an increased risk of acute rejection (risk difference, 6%; 95% CI 2-10%, p = 0.002) but a higher creatinine clearance (mean difference, 7.49 mL/min; 95% CI 5.08-9.89 mL/min, p < 0.00001) at 1 year compared to continued CNI and sirolimus therapy. Graft loss (relative risk, 0.87; 95% CI 0.46-1.64, p = 0.66) and death (relative risk, 0.88; CI 0.40-1.96, p = 0.76) were similar in both groups at 1 year. Hypertension was significantly reduced in the CNI withdrawal group (relative risk, 0.56; 95% CI 0.40-0.78, p = 0.0006). CNI withdrawal from sirolimus-based therapy is associated with an increased risk of acute rejection in the short term with a significant improvement in renal function and a reduction in hypertension. Longer follow-up is needed to determine if these changes will result in a significant improvement in patient and graft survival. 相似文献
83.
Cristiano Feijó Andrade Thomas K. Waddell Shaf Keshavjee Mingyao Liu 《American journal of transplantation》2005,5(5):969-975
Traditionally, the recognition and tolerance of transplanted grafts has been considered to be within the realm of the adaptive immune system. Innate immunity, on the other hand, as the first line of host defense, plays a role in fighting against invading microorganisms. Recently, with the discovery of the Toll-like receptors (TLRs), the role of innate immune responses in the control of adaptive immunity has become a new area of interest. Emerging evidence suggests that in addition to responding to pathogen-associated molecular patterns of microorganisms, TLRs can be activated by endogenous ligands, expressed by mammalian cells. These 'danger signals' may participate in ischemia-reperfusion related organ damage and subsequently influence function and survival of transplanted grafts. Furthermore, it has been suggested that adaptive immune responses can enhance the acute inflammatory responses controlled by innate immunity in organ transplantation. This review addresses the potential involvement of TLRs in different stages of organ transplantation. Intriguing and controversial findings are presented and discussed in order to stimulate more attention to this emerging and potentially important area of research in organ transplantation. 相似文献
84.
W. E. Uber S. E. Self A. B. Van Bakel N. L. Pereira 《American journal of transplantation》2007,7(9):2064-2074
Acute antibody-mediated rejection (AMR) in heart transplantation is often associated with hemodynamic compromise, and is associated with increased mortality and development of accelerated transplant coronary artery disease (TCAD). The diagnosis of AMR has historically been controversial and outcomes with aggressive immunosuppressive therapy including plasmapheresis and cyclophosphamide are poor. Advances in diagnostic techniques like the demonstration of immunopathologic evidence for antibody-mediated rejection by deposition of the complement split product C4d in tissue and detection of anti-HLA antibodies by flow cytometry will assist in further characterizing AMR. Immunosuppression targeting B-lymphocytes and use of m-TOR inhibitors to alter the predilection to develop TCAD and improve survival in AMR remains to be proven. 相似文献
85.
Heightened Expression of the Cytotoxicity Receptor NKG2D Correlates with Acute and Chronic Nephropathy After Kidney Transplantation 总被引:4,自引:0,他引:4
86.
K. Murata K. Fox-Talbot Z. Qian K. Takahashi G. L. Stahl W. M. Baldwin III B. A. Wasowska 《American journal of transplantation》2007,7(11):2605-2614
The role of non-complement-activating alloantibodies in humoral graft rejection is unclear. We hypothesized that the non-complement-activating alloantibodies synergistically activate complement in combination with complement-activating antibodies. B10.A hearts were transplanted into immunoglobulin knock out (Ig-KO) mice reconstituted with monoclonal antibodies to MHC class I antigens. In allografts of unreconstituted Ig-KO recipients, no C4d was detected. Similarly, reconstitution with IgG1 or low dose IgG2b alloantibodies did not induce C4d deposition. However, mice administered with a low dose of IgG2b combined with IgG1 had heavy linear deposits of C4d on vascular endothelium. C4d deposits correlated with decreased graft survival. To replicate this synergy in vitro, mononuclear cells from B10.A mice were incubated with antibodies to MHC class I antigens followed by incubation in normal mouse serum. Flow cytometry revealed that both IgG2a and IgG2b synergized with IgG1 to deposit C4d. This synergy was significantly decreased in mouse serum deficient in mannose binding lectin (MBL) and in serum deficient in C1q. Reconstitution of MBL-A/C knock out (MBL-KO) serum with C1q-knock out (C1q-KO) serum reestablished the synergistic activity. This suggests a novel role for non-complement-activating alloantibodies and MBL in humoral rejection. 相似文献
87.
Debbie Ehrmann Feldman Mirella de Civita Patricia L. Dobkin Pete Malleson Garbis Meshefedjian CiarÁn M. Duffy 《Arthritis care & research》2007,57(2):226-233
Objective
To document perceived adherence to treatment (taking medications and performing exercises) in patients with juvenile idiopathic arthritis (JIA) over a 1‐year period and to identify related factors.Methods
We surveyed parents of patients with JIA at the Montreal Children's Hospital and British Columbia's Children's Hospital in Vancouver. Parents were asked to respond to a series of questionnaires every 3 months over a 12‐month period. Perceived adherence was evaluated on a 100‐mm visual analog scale (VAS) in the Parent Adherence Report Questionnaire (PARQ). Parental coping, distress, child function, disease severity and duration, perceived helpfulness of treatment, problems encountered, and sociodemographic data were also assessed.Results
The mean age of our sample of 175 children was 10.2 years; mean age at diagnosis was 6.1 years and mean disease duration was 4.1 years. Perceived adherence to medications was consistently high, with average adherence at baseline, 3, 6, 9, and 12 months being 86.1, 91.7, 90.4, 92.0, and 88.8, respectively, on the PARQ VAS. Perceived adherence to exercise was lower but remained steady, with corresponding means of 54.5, 64.1, 61.2, 63.0, and 54.3, respectively. Using generalized estimating equation analysis, factors associated with higher perceived adherence to medications included perceived helpfulness of medications and lower disease severity; those associated with higher perceived adherence to exercise were younger age of the child, child involvement in responsibility for treatment, and higher perceived helpfulness of the treatment.Conclusion
Belief in helpfulness of treatment is associated with higher parental perceived adherence to treatment. 相似文献88.
Anthony P. Khalifah Ramsey R. Hachem Murali M. Chakinala Roger D. Yusen Aviva Aloush G. Alexander Patterson Thalachallour Mohanakumar Elbert P. Trulock Michael J. Walter 《American journal of transplantation》2005,5(8):2022-2030
Bronchiolitis obliterans syndrome (BOS) is a major cause of lung allograft dysfunction. Although previous studies have identified mild to severe rejection (grade>or=A2) as a risk factor for BOS, the role of minimal rejection (grade A1) remains unclear. To determine if A1 rejection by itself is a risk factor for BOS, we performed a retrospective cohort study on 228 adult lung transplant recipients over a 7-year period. Cohorts were defined by their most severe rejection episode (none, A1 only, and >or=A2) and analyzed for the subsequent development and progression of BOS using univariate and multivariate time-dependent Cox regression analysis. In the univariate model, the occurrence of isolated minimal rejection was a risk factor for all stages of BOS. Similarly, multivariate models that included HLA mismatch, cytomegalovirus pneumonitis, community acquired viral infection, underlying disease and type of transplant demonstrated that A1 rejection was a distinct risk factor for BOS. Furthermore, the associated risk with A1 rejection was slightly greater than the risk from >or=A2 and treatment of A1 rejection decreased the risk for subsequent BOS stage 1. We conclude that minimal rejection is associated with an increased risk for BOS development and progression that is comparable to A2 rejection. 相似文献
89.
Regis A. Vilchez James Dauber Kenneth McCurry Aldo Iacono Shimon Kusne 《American journal of transplantation》2003,3(2):116-120
Parainfluenza virus is a common cause of seasonal upper respiratory tract infections in children and adults. Studies indicate that parainfluenza virus may play an important role in the etiology of respiratory tract infections in lung transplant recipients with an estimated incidence of 5.3 per 100 patients. Parainfluenza virus type 3 is the most frequent serotype in lung transplant patients. The rate of lower respiratory tract infections with parainfluenza virus among lung transplant recipients is between 10 and 66% of cases. In addition, trans-bronchial biopsy at the time of parainfluenza infection shows signs of acute allograft rejection. Subsequently, 32% of patients have been found to have active bronchiolitis obliterans at a median time of 6 months (range 1-14) postviral infection. These findings indicate that parainfluenza virus infections may have long-term implications for lung transplant recipients. Further studies are required to identify the mechanisms of immunomodulation of parainfluenza virus among these patients. In addition, controlled studies are needed to evaluate the efficacy of aerosolized ribavarin in the treatment of parainfluenza virus infection and to determine whether vaccines may be effective in these high-risk patients. 相似文献
90.
R. Brian Fazia Roger M. Mills C. Richard Conti Edward D. Staples 《Clinical cardiology》1996,19(8):672-674
Infective endocarditis is an infrequent but serious complication in heart transplant recipients. We report successful treatment for this serious complication. 相似文献